Paid Clinical Trials in Tacoma, WA
As of August 2026, 151 paid clinical trials are recruiting in Tacoma, Washington. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Tacoma offers studies at sites including Mary Bridge Children's Hospital and Health Center for conditions such as Crohn's Disease, Multiple Myeloma, Ulcerative Colitis, Colitis, Ulcerative. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Tacoma
Trials by drug in Tacoma
Filter results
Newly added in Tacoma
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
148 clinical trials
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
A Study to Evaluate the Optimization of the Cytokine Release Syndrome Profile for Glofitamab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed/Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma
A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer)
A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults
A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC)
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Study Assessing Activity of Intravenous (IV) Etentamig Monotherapy Versus Standard Available Therapies in Adult Participants With Relapsed or Refractory Multiple Myeloma
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval Study
Top Research Study Locations in Tacoma
Researchers run research studies in Tacoma, WA at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Mary Bridge Children's Hospital and Health Center | Acute Myeloid Leukemia, B Acute Lymphoblastic Leukemia, Ganglioneuroblastoma, Nodular | 20 |
| Madigan Army Medical Center | Malignant Solid Neoplasm, Acute Myeloid Leukemia, ACDF Surgery | 18 |
| Northwest Medical Specialties | Breast Cancer, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma | 18 |
| Northwest Medical Specialties, PLLC | Advanced Cancer, Metastatic Cancer, Advanced Solid Tumor | 14 |
| Washington Gastroenterology - Tacoma | Obesity or Overweight, Crohn's Disease, Metabolic Dysfunction-Associated Steatotic Liver Disease | 9 |
| Northwest Medical Specialties Tacoma | Chronic Lymphocytic Leukemia, Multiple Myeloma, Non Small Cell Lung Carcinoma | 6 |
| MultiCare Institute for Research & Innovation | Crohn's Disease, Hypogonadism, Male, Metastatic Non-small Cell Lung Cancer | 4 |
| MultiCare Health System | Breast Neoplasms, Colitis, Ulcerative, Neoplasm Metastasis | 4 |
| Universal Research Group | Alzheimer Disease, Atherosclerotic Cardiovascular Disease (ASCVD), Dementia | 3 |
| 89bio Clinical Study Site | Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis, Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis | 2 |
| Cortex Neurovascular / TRA Union | Migraine Disorders, Chronic Migraine, Chronic Migraine Headache | 2 |
| GI Alliance Tacoma | Colitis, Ulcerative, Crohn Disease | 2 |
| Mary Bridge Children's Hospital & Health Center | Cerebroside Lipidosis Syndrome, Gaucher Disease, Glucocerebrosidase Deficiency Disease | 2 |
| Northwest Medical Specialties PLLC | Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Breast Cancer | 2 |
| Northwest Medical Specialties, PLLC - Tacoma | MF, Metastatic Castration-Resistant Prostate Cancer, Myelofibrosis | 2 |
| Washington Gastroenterology- GIA | Crohn's Disease, Ulcerative Colitis | 2 |
| MultiCare Institute for Research and Innovation | Percutaneous Coronary Intervention, Peripheral Endovascular Intervention, Migraine | 2 |
| MultiCare Mary Bridge Children's Health Center | Type 1 Diabetes Mellitus, Fabry Disease | 2 |
| Mary Bridge Children's Health | Sickle Cell Disease | 1 |
| 019 | Advanced Solid Tumor | 1 |
| Anthos Investigative | Atrial Fibrillation (AF) | 1 |
| CHI Franciscan Research Center | Heart Failure, Obesity | 1 |
| Clinical Study Site | Metastatic Colorectal Cancer (CRC) | 1 |
| Clinical Trial Site | Acid Cholesteryl Ester Hydrolase Deficiency, Type 2, Acid Lipase Deficiency, Cholesterol Ester Storage Disease | 1 |
| CommonSpirit Health Research Institute | Atrial Fibrillation, Stroke, Ischemic, Systemic Embolism | 1 |
Active & Upcoming Studies in Tacoma (2026)
Recruiting trials in Tacoma grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (68 active studies)
- An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC · Phase 3 · AstraZeneca
- Adult Outpatient Linvoseltamab With Tocilizumab Prophylaxis to Mitigate the Risk of Cytokine Release Syndrome (CRS) · Phase 4 · Regeneron Pharmaceuticals
Diabetes & metabolic (10 active studies)
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
- SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes · Phase 2 · SAb Biotherapeutics, Inc.
Neurology & pain (10 active studies)
- EMBRACE-OBS: Single-Site Observational Registry of Patient-Reported Outcomes Following MMA Embolization for Migraine · Cortex Neurovascular
- A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT). · Phase 3 · Eli Lilly and Company
Cardiovascular (10 active studies)
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
- Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention · Phase 4 · Duke University
Mental health & behavior (1 active study)
- Lay-Delivered Behavioral Activation in Senior Centers · University of Washington
Common conditions studied in Tacoma
- Crohn's Disease (8 active studies)
- Multiple Myeloma (7 active studies)
- Ulcerative Colitis (7 active studies)
- Colitis, Ulcerative (6 active studies)
- Breast Cancer (5 active studies)
- Breast Neoplasms (5 active studies)
Leading research sponsors in Tacoma
- Children's Oncology Group
- AstraZeneca
- Eli Lilly and Company
- National Cancer Institute (NCI)
- AbbVie
Frequently asked questions
How many paid clinical trials are currently recruiting in Tacoma?
There are approximately 151 recruiting clinical trials in Tacoma, Washington listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Tacoma pay participants?
Most recruiting trials in Tacoma compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Tacoma?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Tacoma?
The most common conditions under active study in Tacoma include Crohn's Disease (8), Multiple Myeloma (7), Ulcerative Colitis (7), Colitis, Ulcerative (6), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Tacoma?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Tacoma on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Tacoma?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Tacoma?
Recruiting research sites in Tacoma include Mary Bridge Children's Hospital and Health Center, Madigan Army Medical Center, Northwest Medical Specialties, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Tacoma right now?
The largest active categories in Tacoma are Cancer & tumors (68), Diabetes & metabolic (10), Neurology & pain (10). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.